Perimeter Solutions Reports Fourth Quarter 2025 Financial Results

Core Insights - Perimeter Solutions, Inc. reported a full year net loss of $206.4 million and an adjusted net income of $206.7 million for the year ended December 31, 2025, indicating significant financial challenges despite some operational successes [1][5][33] - The company achieved a full year adjusted EBITDA of $331.7 million, reflecting an 18% increase from the previous year, driven by strong performance in its Specialty Products segment [1][5][33] - The company experienced a loss per diluted share of $1.37, compared to a loss of $0.04 per diluted share in the prior year, highlighting a substantial decline in profitability [1][5][33] Financial Performance - Net sales for the full year increased by 16% to $652.9 million, up from $561.0 million in the prior year, with the Fire Safety segment contributing $489.0 million and the Specialty Products segment contributing $163.9 million [5][33] - In the fourth quarter, net sales rose by 19% to $102.8 million compared to $86.2 million in the same quarter of the previous year, with Specialty Products net sales surging by 75% [5][33] - The adjusted EBITDA for the fourth quarter increased by 9% to $36.0 million, compared to $32.9 million in the prior year quarter, indicating improved operational efficiency [5][33] Segment Performance - The Fire Safety segment's adjusted EBITDA increased by 21% to $290.5 million for the full year, while the Specialty Products segment's adjusted EBITDA saw a modest increase of 3% to $41.2 million [5][33] - In the fourth quarter, the Fire Safety segment's adjusted EBITDA decreased by 6% to $25.6 million, contrasting with the Specialty Products segment's adjusted EBITDA, which increased by 85% to $10.4 million [5][33] Capital Allocation and Acquisitions - The company invested $7.0 million in capital expenditures during the fourth quarter and $29.6 million for the full year, reflecting ongoing investment in growth initiatives [5][33] - Perimeter Solutions acquired certain electro-optical product lines for $40.0 million in November 2025 and the outstanding capital stock of Medical Manufacturing Technologies, LLC for $685.0 million in January 2026, both aimed at enhancing its Specialty Products segment [6][5][33] Stockholder Information - The company reported a weighted average number of shares outstanding of 150.4 million for the year ended December 31, 2025, which is an increase from 145.7 million in the previous year [33] - The adjusted earnings per diluted share for the full year was $1.34, compared to $1.11 in the prior year, indicating a positive trend in adjusted profitability metrics [1][5][33]